199 related articles for article (PubMed ID: 29548009)
41. Vancomycin-resistant enterococcal bacteraemia: is daptomycin as effective as linezolid?
Mave V; Garcia-Diaz J; Islam T; Hasbun R
J Antimicrob Chemother; 2009 Jul; 64(1):175-80. PubMed ID: 19423543
[TBL] [Abstract][Full Text] [Related]
42. Determination of risk factors associated with isolation of linezolid-resistant strains of vancomycin-resistant Enterococcus.
Pogue JM; Paterson DL; Pasculle AW; Potoski BA
Infect Control Hosp Epidemiol; 2007 Dec; 28(12):1382-8. PubMed ID: 17994519
[TBL] [Abstract][Full Text] [Related]
43. Vancomycin-resistant enterococcal bacteraemia and daptomycin: are higher doses necessary?
King EA; McCoy D; Desai S; Nyirenda T; Bicking K
J Antimicrob Chemother; 2011 Sep; 66(9):2112-8. PubMed ID: 21697178
[TBL] [Abstract][Full Text] [Related]
44. Risk factors for rectal colonization with vancomycin-resistant enterococci in Shiraz, Iran.
Askarian M; Afkhamzadeh R; Monabbati A; Daxboeck F; Assadian O
Int J Infect Dis; 2008 Mar; 12(2):171-5. PubMed ID: 17855141
[TBL] [Abstract][Full Text] [Related]
45. Vancomycin-resistant enterococcus bacteraemia in an endemic region: clinical features and genomic analysis: a 12-year cohort.
Abu-Lybdeh O; Murik O; Oster Y; Assous MV; Mann T; Zeevi DA; Benenson S; Wiener-Well Y
J Hosp Infect; 2022 Mar; 121():105-113. PubMed ID: 34896188
[TBL] [Abstract][Full Text] [Related]
46. The prevalence of colonization with vancomycin-resistant Enterococcus at a Veterans' Affairs institution.
Tokars JI; Satake S; Rimland D; Carson L; Miller ER; Killum E; Sinkowitz-Cochran RL; Arduino MJ; Tenover FC; Marston B; Jarvis WR
Infect Control Hosp Epidemiol; 1999 Mar; 20(3):171-5. PubMed ID: 10100542
[TBL] [Abstract][Full Text] [Related]
47. Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patients.
Ghanem G; Hachem R; Jiang Y; Chemaly RF; Raad I
Infect Control Hosp Epidemiol; 2007 Sep; 28(9):1054-9. PubMed ID: 17932826
[TBL] [Abstract][Full Text] [Related]
48. Risk-factors and predictors of mortality in patients colonised with vancomycin-resistant enterococci.
Sakka V; Tsiodras S; Galani L; Antoniadou A; Souli M; Galani I; Pantelaki M; Siafakas N; Zerva L; Giamarellou H
Clin Microbiol Infect; 2008 Jan; 14(1):14-21. PubMed ID: 18005178
[TBL] [Abstract][Full Text] [Related]
49. Molecular epidemiology of vancomycin-resistant enterococcal bacteraemia: results from the Canadian Nosocomial Infection Surveillance Program, 1999-2009.
McCracken M; Wong A; Mitchell R; Gravel D; Conly J; Embil J; Johnston L; Matlow A; Ormiston D; Simor AE; Smith S; Du T; Hizon R; Mulvey MR;
J Antimicrob Chemother; 2013 Jul; 68(7):1505-9. PubMed ID: 23524466
[TBL] [Abstract][Full Text] [Related]
50. Significant reduction in vancomycin-resistant enterococcus colonization and bacteraemia after introduction of a bleach-based cleaning-disinfection programme.
Grabsch EA; Mahony AA; Cameron DR; Martin RD; Heland M; Davey P; Petty M; Xie S; Grayson ML
J Hosp Infect; 2012 Dec; 82(4):234-42. PubMed ID: 23103245
[TBL] [Abstract][Full Text] [Related]
51. [Vancomycin resistant enterococci in Austria].
Allerberger F; Lass-Flörl C; Dierich MP; Hirschl AM; Presterl E; Haas G; Klare I; Witte W
Wien Klin Wochenschr; 1997 May; 109(9):312-20. PubMed ID: 9265389
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of the treatment of vancomycin-resistant enterococcal urinary tract infections in a large academic medical center.
Heintz BH; Cho S; Fujioka A; Li J; Halilovic J
Ann Pharmacother; 2013 Feb; 47(2):159-69. PubMed ID: 23341161
[TBL] [Abstract][Full Text] [Related]
53. Previous antibiotic therapy as independent risk factor for the presence of vancomycin-resistant enterococci in surgical inpatients. Results from a matched case-control study.
MacKenzie P; Färber J; Post M; Esser T; Bechmann L; Kropf S; Croner R; Geginat G
BMC Infect Dis; 2023 May; 23(1):274. PubMed ID: 37131139
[TBL] [Abstract][Full Text] [Related]
54. The clinical and molecular epidemiology of pre-transplant vancomycin-resistant enterococci colonization among liver transplant recipients.
Banach DB; Peaper DR; Fortune BE; Emre S; Dembry LM
Clin Transplant; 2016 Mar; 30(3):306-11. PubMed ID: 26780305
[TBL] [Abstract][Full Text] [Related]
55. Does vancomycin prescribing intervention affect vancomycin-resistant enterococcus infection and colonization in hospitals? A systematic review.
de Bruin MA; Riley LW
BMC Infect Dis; 2007 Apr; 7():24. PubMed ID: 17425800
[TBL] [Abstract][Full Text] [Related]
56. Risk factors for acquiring vancomycin-resistant Enterococcus and methicillin-resistant Staphylococcus aureus on a burn surgery step-down unit.
Wibbenmeyer L; Williams I; Ward M; Xiao X; Light T; Latenser B; Lewis R; Kealey GP; Herwaldt L
J Burn Care Res; 2010; 31(2):269-79. PubMed ID: 20182380
[TBL] [Abstract][Full Text] [Related]
57. Correlation between Nosocomial Carriage of Vancomycin-Resistant Enterococci and Antimicrobial Use in Taiwan.
Lee MC; Lu CH; Lee WY; Lee CM
Am J Trop Med Hyg; 2020 Dec; 104(3):1131-1136. PubMed ID: 33319735
[TBL] [Abstract][Full Text] [Related]
58. The local hospital milieu and healthcare-associated vancomycin-resistant enterococcus acquisition.
Zhou MJ; Li J; Salmasian H; Zachariah P; Yang YX; Freedberg DE
J Hosp Infect; 2019 Jan; 101(1):69-75. PubMed ID: 30026006
[TBL] [Abstract][Full Text] [Related]
59. Antibiotic exposure and room contamination among patients colonized with vancomycin-resistant enterococci.
Drees M; Snydman DR; Schmid CH; Barefoot L; Hansjosten K; Vue PM; Cronin M; Nasraway SA; Golan Y
Infect Control Hosp Epidemiol; 2008 Aug; 29(8):709-15. PubMed ID: 18631116
[TBL] [Abstract][Full Text] [Related]
60. A retrospective cohort study of antibiotic exposure and vancomycin-resistant Enterococcus recolonization.
Hughes HY; Odom RT; Michelin AV; Snitkin ES; Sinaii N; Milstone AM; Henderson DK; Palmore TN
Infect Control Hosp Epidemiol; 2019 Apr; 40(4):414-419. PubMed ID: 30729903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
